Gurnet Point Capital — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Tremeau Pharmaceuticalstremeau.cominOct 2016
Tremeau develops non-opioid pain therapies for patient populations with high unmet medical needs.
BiotechHealthtechCambridge, US
Bradford C. Sippy(Executive Officer, Director)Benjamin Enerson(Executive Officer)Mark Corrigan(Executive Officer)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.